Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome (MDS) Using Treosulfan Based Compared to Standard Reduced-Intensity or Myeloablative Conditioning Regimens. a Report of the Chronic Malignancies Working Party of EBMT-MedSci.cn - 梅斯（MedSci）

Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome (MDS) Using Treosulfan Based Compared to Standard Reduced-Intensity or Myeloablative Conditioning Regimens. a Report of the Chronic Malignancies Working Party of EBMT

Shimoni, A; Robin, M; Iacobelli, S; van Biezen, A; Beelen, DW; Mufti, GJ; Ciceri, F; Kanz, L; Volin, L; Blaise, D; Ganser, A; Luft, T; Chevallier, P; Schwerdtfeger, R; de Witte, T; Kroger, N; Nagler, A; Yakoub-Agha, I

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020; 26 (3): S35

科室
- - 订阅+
  - 更多科室
工具
服务